Photodynamic Therapy of Bladder Cancer – A Phase I Study Using Hexaminolevulinate (HAL) (Q83727779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

title

Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Photodynamic Therapy of Bladder Cancer – A Phase I Study Using Hexaminolevulinate (HAL) (English)

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

28 December 2024

1 reference

10

Christian G Stief

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Herbert Stepp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Wolfgang Beyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Thomas Pongratz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Ronald Sroka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Martin Kriegmair

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Dirk Zaak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Mona Welschof

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Derya Tilki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

Raphaela Waidelich

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

M. J. Bader

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22440147

28 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22440147

28 December 2024

publication date

21 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

full work available at URL

26 January 2020

https://api.elsevier.com/content/article/PII:S1078143912000609?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

https://api.elsevier.com/content/article/PII:S1078143912000609?httpAccept=text/plain

28 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

28 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1178-1183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Photodynamic diagnosis in urology: state-of-the-art

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Photodynamic therapy for superficial bladder cancer under local anaesthetic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

The photosensitizing effect of the photoproduct of protoporphyrin IX.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

Effectiveness and cost-effectiveness of arthroscopic lavage in the treatment of osteoarthritis of the knee: a mixed methods study of the feasibility of conducting a surgical placebo-controlled trial (the KORAL study)

7 January 2021

21

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2012.02.007

28 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22440147 AND SRC:MED&resulttype=core&format=json

26 January 2020

1 reference